How Does Alcohol Consumption Impact Cancer Risk?
The AACR Cancer Progress Report 2024 detailed the connection between alcohol consumption and the increased risk of certain cancers.
Progress Against Cancer
The AACR Cancer Progress Report 2024 detailed the connection between alcohol consumption and the increased risk of certain cancers.
At the San Antonio Breast Cancer Symposium, experts discussed the implications of sexual health, supplements, exercise, and diet for patients with breast cancer.
Findings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
New year brings debate about dangers of alcohol, and insurance denials continue to delay care.
This month, the editors of the AACR journals highlighted studies about the gut microbiome in lung cancer, modeling the risk of adenoma progression, and more.
The FDA approved nivolumab and hyaluronidase-nvhy as an injectable therapy for multiple tumor types. The U.S. Food and Drug Administration (FDA) has approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for subcutaneous (under the skin) injection...
Our favorite Cancer Today stories from 2024, as picked by the editors.
The Cancer Today editors share the most impactful reporting on cancer research from 2024.
In 2024, the American Association for Cancer Research (AACR) released the 14th edition of the annual AACR Cancer Progress Report and the third edition of the biennial AACR Cancer Disparities Progress Report that highlight...
The FDA approved the kinase inhibitors encorafenib and cetuximab plus chemotherapy for the treatment of certain colorectal cancers. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to encorafenib (Braftovi), in combination...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More